World Journal of Surgery

, 35:2268

Long-Term Results of Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma: A Case-Matched Analysis

Authors

    • Department of SurgeryPrince of Wales Hospital, the Chinese University of Hong Kong
  • Ching Ning Chong
    • Department of SurgeryPrince of Wales Hospital, the Chinese University of Hong Kong
  • Jeff Wong
    • Department of SurgeryPrince of Wales Hospital, the Chinese University of Hong Kong
  • Yue Sun Cheung
    • Department of SurgeryPrince of Wales Hospital, the Chinese University of Hong Kong
  • John Wong
    • Department of SurgeryPrince of Wales Hospital, the Chinese University of Hong Kong
  • Paul Lai
    • Department of SurgeryPrince of Wales Hospital, the Chinese University of Hong Kong
Article

DOI: 10.1007/s00268-011-1212-6

Cite this article as:
Lee, K.F., Chong, C.N., Wong, J. et al. World J Surg (2011) 35: 2268. doi:10.1007/s00268-011-1212-6

Abstract

Background

Laparoscopic hepatectomy (LH) is established as a safe and feasible treatment option for liver tumors. However, whether the adoption of laparoscopic approach for malignant tumors, such as hepatocellular carcinoma (HCC), will compromise the long-term result is still unknown. This study was designed to evaluate the long-term results of LH compared with a cohort of case-matched open hepatectomy (OH).

Methods

Thirty-three patients who underwent LH for HCC in our institution between June 2004 and March 2010 were recruited. A group of 50 patients who underwent OH for HCC during the same period was identified by matching to magnitude of operation, size of tumor, site of tumor, and the absence of concomitant local ablation or major procedure. The perioperative outcomes, disease recurrence, and survival of the two groups of patients were determined and compared.

Results

LH resulted in less operative complications (6.1% vs. 24%, P = 0.033) and shorter median hospital stay (5 vs. 7 days, P < 0.0005) but required longer operative time compared with OH (225 vs. 195 min, P = 0.019). There was no difference between LH and OH in recurrence rate (45.5% vs. 38%, P = 0.499). The 1-, 3-, and 5-year overall survival were 86.9%, 81.8%, and 76% for LH and 98%, 80.6%, and 76.1% for OH respectively (P = 0.646). The 1-, 3-, and 5-year disease-free survival were 78.8%, 51%, and 45.3% for LH and 69.2%, 55.9%, and 55.9% for OH, respectively (P = 0.849).

Conclusions

Compared with OH, LH for HCC has similar long-term outcomes, but it has short-term advantages of less operative complications and shorter hospital stay.

Copyright information

© Société Internationale de Chirurgie 2011